Heart Disease
Heart Disease Ongoing 2019


To evaluate a new medication for the treatment of patients in heart failure with a reduced ejection fraction and with iron deficiency.

Trial overview

Structural Heart Disease
Eligibility criteria

To be considered for the study you must meet the following criteria:

  • 18 years of age or older
  • History of stable heart failure
  • At last one admission to hospital for heart failure within the last 12 months
  • Reduced left ventricular ejection fraction
  • Able to perform 6-minute walk test
Study details

Your participation in this study will last between 1 year and 3½ years

You will be required to attend the clinic for 3 initial visits (Screen, Day 0 & Day 7) and a visit every 6 months. During these visits, you will receive your medication dose, have a physical examination, blood tests and a 6-minute walk test performed. You will also receive a 3 monthly telephone call to ask about your health and medications

You will be reimbursed for travel and study-related expenses.

Sign up to this clinical trial here.


Dr David B Cross


General cardiologist

Works at 4 centres.